A peer-reviewed validation of droplet digital PCR as a powerful tool for cell therapy studies

Cell and gene therapies have gained increased attention in recent years due to their potential to treat a variety of diseases, including cancer, autoimmune diseases, and genetic disorders. In this application note from Bio-Rad, explore results from a recent study, where authors note that existing qPCR assays quantifying Arthrobacter luteus (Alu) elements (Alu-qPCR) or the retrotransposon LINE1 (LINE1-qPCR) have several drawbacks. Furthermore, discover how the use of ddPCR technology allows assays to be run with a single surrogate calibration curve and optimized for multiplexing.